期刊文献+

硒结合蛋白-1 Caspase-3 Ki-67在子宫内膜癌中的表达及意义 被引量:2

Expressions and biological significance of SBP-1, Caspase-3 and Ki-67 in endometrial cancer
下载PDF
导出
摘要 目的探讨硒结合蛋白(SBP)-1、Caspase-3、Ki-67在子宫内膜癌中的表达及其生物学意义,为子宫内膜癌的早期诊断及预后判定提供实验依据。方法用免疫组织化学Envision法检测SBP-1、Caspase-3、Ki-67在70例子宫内膜癌中的表达,并选取25例子宫内膜非典型增生和20名正常子宫内膜进行对照分析。结果在正常子宫内膜中SBP-1、Caspase-3、Ki-67阳性表达率分别为95%、100%、5%;在子宫内膜非典型增生中SBP-1、Caspase-3、Ki-67阳性表达率分别为80%、72%、60%;在子宫内膜癌中分别为60%、50%、74%。SBP-1、Caspase-3、Ki-67分别在正常子宫内膜、子宫内膜非典型增生和子宫内膜癌中的表达差异有统计学意义(P<0.05)。SBP-1在子宫内膜癌中的表达与年龄无关(P>0.05),与组织病理分级、临床分期和肌层浸润深度及淋巴转移有关(P<0.05)。Caspase-3在子宫内膜癌中的表达与年龄、临床分期和肌层浸润深度及淋巴转移无关(P>0.05),与组织病理分级有关(P<0.05)。Ki-67在子宫内膜癌中的表达与组织病理分级和临床分期、肌层浸润深度及淋巴转移有关(P<0.05),与年龄无关(P>0.05)。在子宫内膜癌中,SBP-1与Caspase-3的表达呈显著正相关(r=0.467,P<0.05),SBP-1与Ki-67的表达呈显著负相关(r=-0.414,P<0.05),Caspase-3与Ki-67的表达呈显著负相关(r=-0.523,P<0.05)。结论 SBP-1、Caspase-3、Ki-67可作为子宫内膜癌组织的标记物,其相关性有助于子宫内膜癌的早期诊断及预后判定。 Objective To investigate the expressions and biological significance of SBP-1, Caspase-3 and Ki-67 in endometrial cancer, so as to provide laboratory evidences for early diagnosis and prognosis estimation. Methods The expressions of SBP-1, Caspase-3 and Ki-67 in 70 cases of endometrial carcinoma were determined using im- munohistochemical envision methods, and compared with findings from 25 cases of atypical endometrial hyperplasia and 20 of normal endometrial tissues. Results The expressions of SBP-1, Caspase-3 and Ki-67 were positive in 95%, 100% and 5% of normal endometrium, 80%, 72% and 60% of atypical endometrial hyperplasia cases, 60%, 50% and 74% of endometrial carcinoma, respectively. These differences in expressions of SBP-1, Caspase-3 and Ki-67 in normal endometrium, atypical endometrial hyperplasia and endometrial cancer appeared significant (P0.05). The ex- pression of SBP-1 in endometrial cancer was related to histopathological grades, clinical stages, depth of myometrial invasion and lymph node metastasis (P0.05) but not to age (P0.05). The expression of Caspase-3 in endometrial car- cinoma was related to histopathological grades (P0.05) but not to clinical stages, depth of myometrial invasion, lymph node metastasis and age (P0.05). The expression of Ki-67 in endometrial carcinoma was related to histopathological grades, clinical stages, depth of myometrial invasion and lymph node metastasis (P0.05) but not related to age (P 0.05). In endometrial carcinoma, SBP-1 and Caspase-3 expressions were positively correlated (r=0.467, P0.05),SBP-1 and Ki-67 expressions negatively correlated (r=-0.414, P0.05), Caspase-3 and Ki-67 expressions negatively correlat- ed (r=-0.523, P0.05). Conclusion SBP-1, Caspase-3 and Ki-67 can be useful as biomarkers in endometrial can- cer, of which, correlations among these markers may contribute to early diagnosis and prognosis estimation.
出处 《中国药物与临床》 CAS 2010年第7期744-747,共4页 Chinese Remedies & Clinics
基金 山西省归国留学人员专用基金(200856)
关键词 子宫内膜肿瘤 免疫组织化学 生物医学研究 Endometrial neoplasma Immunohistochemistry Biomedical research
  • 相关文献

参考文献12

  • 1李玉林.病理学.北京:人民卫生出版社,2003:354-357.
  • 2Schrauzer GN,Thead WJ.Interpretation of the methylene blue reduction test of human plasma and the possible cancer protecting effect of selenium.Experientia(Basel),1971,27:1069-1071.
  • 3Yang M,Sytowski AI.Differential expression and androgen regulation of the human selenium binding protein gene hSP56 in prostate cancer ceils.Cancer Res,1998,58:3150-3153.
  • 4Hasegawa M,Yagi K,lwakawa S,et al.Chitnsan induces apoptosis via easpase-3 activaion in bladder tumor cell.Jap J Cancer Res,2001,92(4):459-466.
  • 5Wang J,Lenardo MJ.Roles of caspase in apoptosis,development,and eytokine maturation revealed by omozygous gene deficiencies.J Cell Sci,2000,113(Pt 5):753-757.
  • 6El-Bayoumy K.The protective role of selenium on genetic damage and cancer.Mutat Res,2001,475:123-139.
  • 7Koseki T,Inohara N,Chen S,et al.ARC,an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts slectively with caspases.Proc Natl Sci USA,1998,95(9):5156-5160.
  • 8Peiro G,Diebold J,Baretton GB,et al.Cellular apoptosis susceptiblity gene expression in endometrial carcinoma:correlation with Bel-2,Bax,Caspase-3 expression and outcome.Int J Gynecol Pathi1,2001,20(4):359-367.
  • 9佟盛春,张岩,王永来.Fhit蛋白和PCNA在子宫内膜癌中的表达及意义[J].山西医药杂志(上半月),2008,37(2):105-109. 被引量:7
  • 10彭德强,白慧婧,张三元.丙氨瑞林对人子宫内膜癌裸鼠移植瘤生长抑制作用研究[J].中国药物与临床,2009,9(10):952-954. 被引量:1

二级参考文献24

  • 1徐虹,宋磊.子宫内膜癌的激素治疗进展[J].现代妇产科进展,2007,16(1):62-64. 被引量:6
  • 2Johnson ME,Howerth EW.Survivin:a bifunctional inhibitor of apoptosis protein.Vet Pathol, 2004,41 (6) : 599-607.
  • 3Taikai N,Miyazaki T,Nishida M,et al. Survivin expression correlates with clinical stage,histological grade,invasive behavior and survival rate in endometrial carcinoma. Cancer Lett,2002, 184:105-116.
  • 4Lehner R,Enomoto T,McGregor GA,et al. Correlation of surviving mRNA detection with histological diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand, 2002,81 (2): 162-167.
  • 5[2]Ohta M,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint,is abnormal in digestive tract cancers.Cell,1996,84(4):587-597.
  • 6[3]Mori M,Mimori K,Shiraishi T,et al.Altered expression of Fhit in carcinoma and precarcin-omatous lesions of the esophagus.Cancer Res,2000,60(5):1177-1182.
  • 7[4]Rocco A,Schandl L,Chen J,et al.Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.J Cancer Res Clin Oncol,2003,129(2):84-88.
  • 8[5]Andachi H,Yashima K,Koda M,et al.Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.Br J Cancer,2002,87(4):441-445.
  • 9[6]Mascaux C,Martin B,Verdebout JM,et al.Fragile histidine triad protein expression in non-small cell lung cancer and correlation with Ki-67 and with p53.Eur Respir J,2003,21(5):753-758.
  • 10[7]Koch E,Fiedler W,Tannapfel A,et al.Alteration of the fragiletriad histidinetriad gene in intrahepatic cholangiocarcinoma.Eur J Gastroenterol Hepatol,2003,15(8):907-913.

共引文献27

同被引文献17

  • 1aSallam HN, Garcia-Velasco JA, Dias S, et al. Long-term pituitary down-regulalion before in vitro fertilization (IVF) for women with endometriosis[ J ]. Cochrane Data- base Syst Rev,2006,25 (1) :CD004635.
  • 2Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments [ J]. Ann N Y Acad Sci, 2008,1127 (4) :92-100.
  • 3de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility : pathophysiology and management [ J ]. Lancet, 2010,376 (9742) :730-738.
  • 4Bulun SE, Utsunomiya H, Lin Z, et al. Steroidogenic fac- tor-1 and endometriosis [ J ]. Mol Cell Endocrinol, 2009, 300(5 ) : 104-108.
  • 5Lessey BA. Implantation defects in infertile women with endometriosis[ J ]. Ann N Y Acad Sci, 2002,955 (3) : 265 -280,293 -295,396-406.
  • 6Brosens J, Hodgetts A, Feroze- Zaidi F, et al. Proteomic a- nalysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implanta- tion failure and endometriosis [ J ]. Mol Hum Reprod, 2010,16(4) :273-285.
  • 7Chang PW, Tsui SK, Liew C, et al. Isolation, characteriza-tion, and chromosomal mapping of a novel cDNA clone en- coding human selenium binding protein [ J ]. J Cell Bio- chem, 1997,64(2) :217-224.
  • 8Zhang P, Zhang C, Wang X, et al. The expression of sele- nium-binding protein 1 is decreased in uterine leiomyoma [ J ]. Diagn Pathol,2010,9 (5) :80.
  • 9Lee SO, Nadiminty N, Wu XX, et al. Selenium disrupts estrogen signaling by altering estrogen receptor expres- sion and ligand binding in human breast cancer cells [ J]. Cancer Res, 2005,65 ( 8 ): 3487-3492.
  • 10Combs GF Jr.Current evidence and research needs to support a health claim for selenium and cancer prewention[J].J Nutr,2005,135(2):343-347.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部